| Business Summary | | LaserSight
Incorporated
develops,
manufactures
and
markets
product
technologies
for
laser
refractive
surgery
and
other
areas
of
vision
correction.
The
Company's
products
include
precision
beam
microspot
scanning
excimer
laser
systems
used
to
perform
procedures
that
correct
common
refractive
vision
disorders
such
as
nearsightedness
(myopia),
farsightedness
(hyperopia)
and
astigmatism,
as
well
as
keratome
systems,
keratome
blades,
diagnostic
and
other
products
for
use
in
refractive
vision
correction
procedures. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | LASE
develops,
manufactures
and
markets
ophthalmic
lasers
for
use
in
photorefractive
keratectomy
(PRK)
to
correct
myopia,
hyperopia
and
astigmatism.
LASE
also
licenses
related
patents.
For
the
three
months
ended
3/31/01,
revenues
decreased
49%
to
$4.4
million.
Net
loss
decreased
10%
to
$2.5
million.
Revenues
reflect
lower
sales
of
LaserScan
LSX
excimer
laser
system.
Lower
loss
reflects
the
inclusion
of
a
$4
million
gain
on
the
sale
of
a
patent. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
3,467;
after
tax
earnings
were
-8,680. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Francis O'Donnell, Jr., M.D., 51 Chairman | -- | Michael Farris, 41 Pres,
CEO, Director | $276K | Gregory Wilson, 43 CFO | 185K | D. Michael Litscher, 54 COO,
Director | 188K | Christine Oliver, 49 Sr.
VP of Sales and Marketing | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|